Shau-Hsuan Li

10PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 31, 2026
Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

|Mar 13, 2026
A Rare SMARCA4-Deficient Subglottic Adenoid Cystic Carcinoma With Early Pulmonary Metastasis.

Ko-Chun Fang, Fu-Min Fang, Shau-Hsuan Li

|Feb 07, 2026
High PD-1 expression in pre-treatment peripheral lymphocytes associated with poor immune checkpoint inhibitor response in patients with recurrent or metastatic head and neck squamous cell carcinoma.

Shau-Hsuan Li, Wan-Ting Huang

|Nov 03, 2025
Macrocytosis as a risk factor for secondary esophageal cancer in hypopharyngeal cancer patients: a multicenter case-control study.

Ching-Nung Wu, Po-Teng Chiang, Chung-Yi Li

|Jun 12, 2018
The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.

Yen-Hao Chen, Hung-I Lu, Chien-Ming Lo

|Jun 02, 2018
Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy.

Tai-Jan Chiu, Hung-I Lu, Chang-Han Chen

Pageof 2

Frequent Collaborators

4 joint publications

Wei-Che Lin

4 joint publications

Meng-Hsiang Chen

2 joint publications

Cheng-Hsien Lu

1 joint publications

Yu-Jih Su